Get the Stockscreener App
0.8843
1.43%
0.0167
Predictive Oncology Inc stock is traded at $0.8843, with a volume of 30,280.
It is up +1.43% in the last 24 hours and down -20.72% over the past month.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
See More
Previous Close:
$0.8676
Open:
$0.87
24h Volume:
30,280
Relative Volume:
0.01
Market Cap:
$8.73M
Revenue:
$1.52M
Net Income/Loss:
$-13.97M
P/E Ratio:
-0.2899
EPS:
-3.05
Net Cash Flow:
$-13.29M
1W Performance:
-9.96%
1M Performance:
-20.72%
6M Performance:
+35.38%
1Y Performance:
-25.42%
1-Day Range:
$0.85
$0.9194
1-Week Range:
$0.85
$0.9865
52-Week Range:
$0.55
$3.06
Predictive Oncology Inc Stock (POAI) Company Profile
Name
Predictive Oncology Inc
Sector
Industry
Phone
412-432-1500
Address
91 43RD STREET, PITTSBURGH, MN
Compare POAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
POAI
Predictive Oncology Inc
|
0.8843 | 8.73M | 1.52M | -13.97M | -13.29M | -3.05 |
|
ISRG
Intuitive Surgical Inc
|
476.89 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
199.18 | 57.39B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
93.55 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.85 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.48 | 15.88B | 3.90B | 392.30M | 288.10M | 1.95 |
Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Initiated | H.C. Wainwright | Buy |
Predictive Oncology Inc Stock (POAI) Latest News
Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire) - Aktiellt
Predictive Oncology (POAI) Advances in Drug Repurposing with AI Innovations | POAI Stock News - GuruFocus
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs - GlobeNewswire
Revolutionary AI Platform Revives Abandoned Cancer Drugs with Stunning Results - Stock Titan
Predictive Oncology Ends Merger Talks with Renovaro - TipRanks
Renovaro says Predictive Oncology terminates merger transaction - MSN
Health Care Stocks Tumble On Multiple Fronts - Finimize
Renovaro Biosciences faces merger setback with Predictive Oncology By Investing.com - Investing.com Canada
Renovaro Biosciences faces merger setback with Predictive Oncology - Investing.com India
Renovaro Says Predictive Oncology Terminates Merger Transaction With Co - marketscreener.com
Renovaro BioSciences (RENB) Challenges Merger Termination - GuruFocus
Renovaro Biosciences Announces Breach Of Agreement By Predictive Oncology, Legal Action Pending - Nasdaq
Renovaro Says Predictive Oncology Terminates Merger Deal; Shares Fall - MarketScreener
Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewswire
Merger Crisis: Renovaro Threatens Legal Action After Predictive Oncology Backs Out - Stock Titan
Predictive Oncology Reports 2024 Financial Results and Merger Plans - TipRanks
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Predictive Oncology pushing forward with Renovaro merger despite $10.8M loss in 2024 - The Business Journals
Predictive Oncology Advances AI Merger Plans Despite $10.8M Loss: Key Strategic Moves Revealed - Stock Titan
Predictive Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research - Insider Monkey
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Predictive Oncology developed predictive models from 21 compounds from NPDC - TipRanks
Predictive Oncology Successfully Develops Predictive Models - GlobeNewswire
Predictive Oncology (POAI) Stock Surges Following Major Drug Discovery Breakthrough - Stocks Telegraph
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - The Manila Times
Predictive Oncology Develops Advanced Predictive Models for Natural Compounds in Cancer Drug Discovery - Nasdaq
Top 8 AI News Updates Driving Markets Today - Insider Monkey
Milestone Merger Payment with Predictive Oncology to Advance AI - newschannelnebraska.com
Predictive Oncology Sells Skyline Medical Assets To DeRoyal Industries - Nasdaq
Predictive Oncology Sells Skyline Medical Assets to DeRoyal Industries - citybiz
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries to Focus on AI-Driven Drug Discovery - Nasdaq
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewswire
Strategic Pivot: Predictive Oncology Divests Medical Assets for AI-Powered Future - Stock Titan
Predictive Oncology (POAI) Expected to Announce Earnings on Thursday - Defense World
Predictive Oncology to launch ChemoFx assay in Europe - MSN
Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report -
Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Insider Monkey
Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals
MarketsMedicine Hat News - Financial Content
Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail
Milestone Merger Payment made with Predictive Oncology - openPR
Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire
Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times
Renovaro completes first milestone payment for Predictive Oncology deal - TipRanks
Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology - Nasdaq
Can Renovaro's AI Oncology Merger Unlock Value From 150,000+ Tumor Samples? - StockTitan
Can This AI-Powered Oncology Merger Transform Cancer Treatment? First Financing Milestone Reached - StockTitan
Predictive Oncology Inc Stock (POAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):